Design of trials with composite endpoints with the R package compAREdesign

dc.contributor.authorCortés Martínez, Jordi
dc.contributor.authorBofill Roig, Marta
dc.contributor.authorGómez Melis, Guadalupe
dc.contributor.groupUniversitat Politècnica de Catalunya. GRBIO - Grup de Recerca en Bioestadística i Bioinformàtica
dc.contributor.otherUniversitat Politècnica de Catalunya. Departament d'Estadística i Investigació Operativa
dc.date.accessioned2022-11-29T11:03:29Z
dc.date.available2022-11-29T11:03:29Z
dc.date.issued2022-11-04
dc.description.abstractComposite endpoints are widely used as primary endpoints in clinical trials. Designing trials with time-to-event endpoints can be particularly challenging because the proportional hazard assumption usually does not hold when using a composite endpoint, even when the premise remains true for their components. Consequently, the conventional formulae for sample size calculation do not longer apply. We present the R package CompAREdesign by means of which the key elements of trial designs, such as the sample size and effect sizes, can be computed based on the information on the composite endpoint components. CompAREdesign provides the functions to assess the sensitivity and robustness of design calculations to variations in initial values and assumptions. Furthermore, we describe other features of the package, such as functions for the design of trials with binary composite endpoints, and functions to simulate trials with composite endpoints under a wide range of scenarios.
dc.description.peerreviewedPeer Reviewed
dc.description.sponsorshipThis work was supported by the Ministerio de Economía y Competitividad (Spain) under Grant PID2019- 104830RB-I00 and the Departament d’Empresa i Coneixement de la Generalitat de Catalunya (Spain) under Grant 2017 SGR 622 (GRBIO). Marta Bofill Roig is a member of the EU Patient Centric Clinical Trial Platforms (EU-PEARL). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and Children’s Tumor Foundation, Global Alliance for TB Drug Development nonprofit organization, Springworks Therapeutics Inc. This publication reflects the authors’ views. Neither IMI nor the European Union, EFPIA, nor any Associated Partners are responsible for any use that may be made of the information contained herein.
dc.description.versionPostprint (author's final draft)
dc.format.extent17 p.
dc.identifier.citationCortes, J.; Bofill, M.; Gómez Melis, G. Design of trials with composite endpoints with the R package compAREdesign. "ArXiv", 4 Novembre 2022, p. 1-17.
dc.identifier.doi10.48550/arXiv.2211.02535
dc.identifier.issn2331-8422
dc.identifier.otherhttps://arxiv.org/abs/2211.02535
dc.identifier.urihttps://hdl.handle.net/2117/377308
dc.language.isoeng
dc.relation.projectidinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-104830RB-I00/ES/METODOLOGIAS ESTADISTICAS PARA DATOS CLINICOS Y OMICOS Y SUS APLICACIONES EN CIENCIAS DE LA SALUD/
dc.rights.accessOpen Access
dc.rights.licensenameAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectÀrees temàtiques de la UPC::Matemàtiques i estadística::Estadística matemàtica
dc.subject.lcshBiometry
dc.subject.lcshStatistics
dc.subject.lcshPharmaceutical technology
dc.subject.lemacBiometria
dc.subject.lemacEstadística
dc.subject.lemacTecnologia farmacèutica
dc.subject.otherComposite endpoints
dc.subject.otherClinical trial
dc.subject.otherStudy design
dc.subject.otherARE
dc.titleDesign of trials with composite endpoints with the R package compAREdesign
dc.typeArticle
dspace.entity.typePublication
local.citation.authorCortes, J.; Bofill, M.; Gómez Melis, Guadalupe
local.citation.endingPage17
local.citation.publicationNameArXiv
local.citation.startingPage1
local.identifier.drac34861896

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
2022_Cortes_CompareDesign_postprint.pdf
Mida:
592.34 KB
Format:
Adobe Portable Document Format
Descripció:
Artículo principal